Drugplain

Ascomp with Codeine 325 mg/1

Butalbital, Aspirin, Cafeine, and Codeine Phosphate · CAPSULE · LGM PHARMA SOLUTIONS, LLC

No Recall History
Plain English

Ascomp with Codeine is a prescription capsule containing a combination of butalbital (a barbiturate), aspirin (an anti-inflammatory pain reliever), caffeine, and codeine (an opioid) used to treat moderate pain, particularly tension headaches. This medication works through multiple mechanisms to reduce pain and inflammation.

Key Facts

Brand Name
Ascomp with Codeine
Generic Name
Butalbital, Aspirin, Cafeine, and Codeine Phosphate
NDC Code (Product)
79739-6094
Manufacturer
LGM PHARMA SOLUTIONS, LLC
Strength
325 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
DEA Schedule
Schedule III (Controlled)
Application #
ANDA075231
Drug Class
Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]
Marketing Start
11/30/2001

Recall History

No Recall History

Frequently Asked Questions

What is Ascomp with Codeine used for?

Ascomp with Codeine is a prescription capsule containing a combination of butalbital (a barbiturate), aspirin (an anti-inflammatory pain reliever), caffeine, and codeine (an opioid) used to treat moderate pain, particularly tension headaches. This medication works through multiple mechanisms to reduce pain and inflammation.

Is Ascomp with Codeine a controlled substance?

Yes, Ascomp with Codeine is classified as CIII under the DEA Controlled Substances Act.

What is the generic name for Ascomp with Codeine?

The generic name for Ascomp with Codeine is Butalbital, Aspirin, Cafeine, and Codeine Phosphate. There are no other listed brand versions of Butalbital, Aspirin, Cafeine, and Codeine Phosphate.

What is the NDC code for Ascomp with Codeine 325 mg/1?

The NDC (National Drug Code) for Ascomp with Codeine 325 mg/1 is 79739-6094, listed by LGM PHARMA SOLUTIONS, LLC.

Product NDC

79739-6094

Package NDC

79739-6094-1

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)